Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

In Brief This Week: Becton Dickinson, Proscia, Co-Diagnostics, Biocept, and More

Proscia
By Author Proscia | February 4, 2022

Proscia and Sweden’s Uppsala University Hospital announced a multiyear agreement this week to digitize the region’s pathology workflows using Proscia’s Concentriq Dx digital pathology technology. Financial and other terms of the deal were not disclosed. Proscia CEO David West said in a statement that Uppsala aims to achieve full digitization by 2024.

Our website uses cookies. By using this site, you agree to its use of cookies.